Výsledky vyhledávání - "Stefanie A Mortimer"

Akademický článek

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.

Autor: Richard B Lanman, Stefanie A Mortimer, Oliver A Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A Collisson, Stephen G Divers, Dave S B Hoon, E Scott Kopetz, Jeeyun Lee, Petros G Nikolinakos, Arthur M Baca, Bahram G Kermani, Helmy Eltoukhy, AmirAli Talasaz

Publikováno v: PLoS ONE, Vol 10, Iss 10, p e0140712 (2015)

Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively parallel and deep sequencing enables assessment of a comprehensive panel of genomic targets from

Externí odkaz: https://doaj.org/article/133fc4af39b34633abd205b896147ca3

Zobrazit plný text záznamu

Table S6 from The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Autor: AmirAli Talasaz, Richard B. Lanman, Darya I. Chudova, Helmy Eltoukhy, Arthur M. Baca, Rebecca J. Nagy, Justin I. Odegaard, Philip C. Mack, David R. Gandara, Reza Mokhtari, James V. Vowles, Stefanie A. Mortimer, Stephen R. Fairclough, Kimberly C. Banks, Oliver A. Zill

Driver alteration prevalence in the cfDNA cohort versus in TCGA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a00368eed83a7ebaf7ef55aeadce0a6
https://doi.org/10.1158/1078-0432.22470284.v1

Zobrazit plný text záznamu

Supplemental Materials from The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Supplemental Methods, Supplemental References, Supplemental Figure Legends, Figure S1-13, Table S1-5 and S14

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3426a5c012c8b062ed7b409de9e9d680
https://doi.org/10.1158/1078-0432.22470290

Zobrazit plný text záznamu

Data from The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Purpose: Cell-free DNA (cfDNA) sequencing provides a noninvasive method for obtaining actionable genomic information to guide personalized cancer treatment, but the presence of multiple alterations in circulation related to treatment and tumor hetero

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb8eb0e52eb86c9f15f9a125774c668
https://doi.org/10.1158/1078-0432.c.6527498.v1

Zobrazit plný text záznamu

Table S7-12 from The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

Mutual exclusivity statistics for cfDNA alterations in lung adenocarcinoma, breast cancer, and colorectal cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea2ab48268a3d1e033a43bffd4a6797
https://doi.org/10.1158/1078-0432.22470281.v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání